NZ513924A - Composition comprising a tramadol material and a selective cox-2 inhibitor drug - Google Patents

Composition comprising a tramadol material and a selective cox-2 inhibitor drug

Info

Publication number
NZ513924A
NZ513924A NZ513924A NZ51392400A NZ513924A NZ 513924 A NZ513924 A NZ 513924A NZ 513924 A NZ513924 A NZ 513924A NZ 51392400 A NZ51392400 A NZ 51392400A NZ 513924 A NZ513924 A NZ 513924A
Authority
NZ
New Zealand
Prior art keywords
composition
selective cox
inhibitor drug
tramadol material
tramadol
Prior art date
Application number
NZ513924A
Inventor
Ellen E Codd
Rebecca P Martinez
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of NZ513924A publication Critical patent/NZ513924A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NZ513924A 1999-03-01 2000-02-29 Composition comprising a tramadol material and a selective cox-2 inhibitor drug NZ513924A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12202699P 1999-03-01 1999-03-01

Publications (1)

Publication Number Publication Date
NZ513924A true NZ513924A (en) 2001-09-28

Family

ID=22400139

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ513924A NZ513924A (en) 1999-03-01 2000-02-29 Composition comprising a tramadol material and a selective cox-2 inhibitor drug

Country Status (9)

Country Link
EP (1) EP1156855A1 (en)
JP (1) JP2002538176A (en)
CN (1) CN1349423A (en)
AU (1) AU3384200A (en)
CA (1) CA2364127A1 (en)
HK (1) HK1040945A1 (en)
MX (1) MXPA01008903A (en)
NZ (1) NZ513924A (en)
WO (1) WO2000051685A1 (en)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8795332B2 (en) 2002-09-30 2014-08-05 Ethicon, Inc. Barbed sutures
EP1126841B1 (en) * 1998-11-02 2004-12-15 Merck & Co., Inc. Combinations of a 5ht1b/1d agonist and a selective cox-2 inhibitor for the treatment of migraine
WO2003048113A1 (en) 2001-11-30 2003-06-12 Sepracor Inc. Tramadol analogs and uses thereof
US6773450B2 (en) 2002-08-09 2004-08-10 Quill Medical, Inc. Suture anchor and method
US8100940B2 (en) 2002-09-30 2012-01-24 Quill Medical, Inc. Barb configurations for barbed sutures
SI1685829T1 (en) * 2002-11-22 2008-08-31 Gruenenthal Gmbh Use of (1RS,3RS,6RS)-6-dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3-diol for treating inflammatory pain
CA2519189C (en) 2003-05-07 2012-07-17 Osteologix A/S Water-soluble strontium salts for use in treatment of cartilage and/or bone conditions
US7205329B2 (en) 2003-05-30 2007-04-17 Microbia, Inc. Modulators of CRTH2 activity
WO2005037227A2 (en) * 2003-10-16 2005-04-28 Microbia, Inc. Selective cox-2 inhibitors
ES2436755T3 (en) 2004-05-14 2014-01-07 Ethicon Llc Suture devices
US8765178B2 (en) 2006-07-19 2014-07-01 Watson Laboratories, Inc. Controlled release formulations and associated methods
SE532177C2 (en) * 2006-07-24 2009-11-10 P & P Ab A puncture device for an inflatable unit
JP5406716B2 (en) 2006-08-07 2014-02-05 アイアンウッド ファーマシューティカルズ インコーポレイテッド Indole compounds
US20080255612A1 (en) 2007-04-13 2008-10-16 Angiotech Pharmaceuticals, Inc. Self-retaining systems for surgical procedures
US8777987B2 (en) 2007-09-27 2014-07-15 Ethicon, Inc. Self-retaining sutures including tissue retainers having improved strength
US8916077B1 (en) 2007-12-19 2014-12-23 Ethicon, Inc. Self-retaining sutures with retainers formed from molten material
US8118834B1 (en) 2007-12-20 2012-02-21 Angiotech Pharmaceuticals, Inc. Composite self-retaining sutures and method
EP3533399A3 (en) 2008-02-21 2019-10-23 Ethicon LLC Method for elevating retainers on self-retaining sutures
KR101577602B1 (en) 2008-04-15 2015-12-28 에티컨, 엘엘씨 Self-retaining sutures with bi-directional retainers or uni-directional retainers
KR20110065488A (en) * 2008-09-05 2011-06-15 그뤼넨탈 게엠베하 Pharmaceutical combination comprising 6-dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3-diol and an nsaid
US20100069501A1 (en) * 2008-09-05 2010-03-18 Gruenenthal Gmbh Pharmaceutical Composition Comprising 6-Dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3-diol and Paracetamol
EP2177215A1 (en) 2008-10-17 2010-04-21 Laboratorios Del. Dr. Esteve, S.A. Co-crystals of tramadol and NSAIDs
MX339174B (en) 2008-11-03 2016-05-12 Ethicon Llc Length of self-retaining suture and method and device for using the same.
EP2311446A1 (en) * 2009-10-16 2011-04-20 Laboratorios Del. Dr. Esteve, S.A. Compositions comprising Tramadol and Celecoxib in the treatment of pain
ES2402112T3 (en) * 2009-10-16 2013-04-29 Laboratorios Del Dr. Esteve, S.A. Tramadol and coxibs co-crystals
WO2011090628A2 (en) 2009-12-29 2011-07-28 Angiotech Pharmaceuticals, Inc. Bidirectional self-retaining sutures with laser-marked and/or non-laser marked indicia and methods
EP2353594A1 (en) 2010-02-09 2011-08-10 Laboratorios Del. Dr. Esteve, S.A. Compositions comprising tramadol and the co-crystal of celecoxib and L-proline in the treatment of pain
AU2011248117B2 (en) 2010-05-04 2015-01-22 Ethicon, Llc Self-retaining systems having laser-cut retainers
EP2392319A1 (en) * 2010-06-04 2011-12-07 Laboratorios Del. Dr. Esteve, S.A. Pharmaceutical compositions of co-crystals of tramadol and coxibs
CA2801271C (en) 2010-06-11 2018-10-30 Ethicon, Llc Suture delivery tools for endoscopic and robot-assisted surgery and methods
NZ610341A (en) 2010-11-03 2015-05-29 Tissuegen Inc Drug-eluting self-retaining sutures and methods relating thereto
NZ704802A (en) 2010-11-09 2015-12-24 Ethicon Llc Emergency self-retaining sutures and packaging
AR084433A1 (en) 2010-12-22 2013-05-15 Ironwood Pharmaceuticals Inc FAAH INHIBITORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
RU2659454C2 (en) 2011-03-23 2018-07-02 ЭТИКОН ЭлЭлСи Self-retaining variable loop sutures
US20130172931A1 (en) 2011-06-06 2013-07-04 Jeffrey M. Gross Methods and devices for soft palate tissue elevation procedures
MX2016006464A (en) * 2016-05-18 2017-11-17 Laboratorios Liomont S A De C V Pharmaceutical composition of a combination of tramadol-etoricoxib hydrochloride for the treatment of pain.
AU2018332417B2 (en) * 2017-09-15 2023-11-30 Crystalgenomics, Inc. Pharmaceutical composition for treating acute and chronic pain, containing polmacoxib and tramadol
WO2019130049A1 (en) 2017-12-29 2019-07-04 Grünenthal GmbH Pharmaceutical combination comprising extended-release tramadol hydrochloride and immediate-release etoricoxib, and its use for the treatment of pain
KR102631399B1 (en) 2018-03-30 2024-02-01 씨지인바이츠 주식회사 Pharmaceutical composition comprising polmacoxib and pregabalin for treatment of pain
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU661723B2 (en) * 1991-10-30 1995-08-03 Mcneilab, Inc. Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug
JP2636819B2 (en) * 1994-12-20 1997-07-30 日本たばこ産業株式会社 Oxazole-based heterocyclic aromatic compounds
BR9711151A (en) * 1996-08-14 1999-08-17 Searle & Co Crystalline form of 4-¬5-methyl-3-phenylsoxazol-4-yl¾benzenesulfonamide
US5919826A (en) * 1996-10-24 1999-07-06 Algos Pharmaceutical Corporation Method of alleviating pain
WO1998050075A1 (en) * 1997-05-07 1998-11-12 Algos Pharmaceutical Corporation Cox-2 inhibitors in combination with nmda-blockers for treating pain
RS49982B (en) * 1997-09-17 2008-09-29 Euro-Celtique S.A., Synergistic analgesic combination of opioid analgesic and cyclooxygenase-2 inhibitor
AU1398899A (en) * 1998-11-12 2000-06-05 Algos Pharmaceutical Corporation Cox-2 inhibitors in combination with centrally acting analgesics

Also Published As

Publication number Publication date
MXPA01008903A (en) 2003-07-21
HK1040945A1 (en) 2002-06-28
CA2364127A1 (en) 2000-09-08
AU3384200A (en) 2000-09-21
WO2000051685A1 (en) 2000-09-08
EP1156855A1 (en) 2001-11-28
CN1349423A (en) 2002-05-15
JP2002538176A (en) 2002-11-12

Similar Documents

Publication Publication Date Title
NZ513924A (en) Composition comprising a tramadol material and a selective cox-2 inhibitor drug
IL148019A0 (en) Composition comprising a tramadol material and an anticonvulsant drug
IS5794A (en) A pharmaceutical composition containing COX-2 inhibitor and iNOS inhibitor
GB0021882D0 (en) Combining material and data
HK1084716A1 (en) A holding and sealing mat material
IL150418A0 (en) Trifluoromethylpyrrole carboxamides and trifluoromethylpyrrolethioamides as fungicides
HK1040995A1 (en) 2-oxoquinoline compounds and medicinal uses thereof
HUP0301868A3 (en) Pharmaceutical composition comprising a factor viia and a factor xiii
HUP0203728A3 (en) Aerosol composition comprising formoterol
EP1340728A4 (en) Composition for building material and building material
EP1079034A4 (en) Joint material and execution method thereof
GB0004016D0 (en) Biological material and uses thereof
GB2396815B (en) A composition comprising a pregnenone derivative and an NSAID
GB0022617D0 (en) Recording material and method
HUP0201880A3 (en) Pharmaceutical composition containing sibutramine and a lipase inhibitor
AU2001294058A1 (en) A rotary soil engaging member and a material for use therein
GB0224848D0 (en) Packaging and packaging material
HUP0302371A3 (en) New pharmaceutical composition comprising a betablocker and optionally a cholesterol-lowering agent
DE60026493D1 (en) Blattförmiges photohärtbares material
GB9901897D0 (en) Biological material and use thereof
HUP0500955A3 (en) Cucurbitacin-containing insecticidal composition and a process for its use
GB9907469D0 (en) Labels and manufacture thereof
DK1210118T3 (en) Composition comprising a tramadol material and an anticonvulsant drug
GB9927769D0 (en) Biological material and uses thereof
HK1029961A1 (en) A building material and its houses.

Legal Events

Date Code Title Description
AABA Application abandoned